FIELD: chemistry.
SUBSTANCE: invention relates to the field of organic chemistry, namely the heterocyclic compounds of the structures mentioned below and to their pharmaceutically acceptable salts. Invention also relates to a pharmaceutical composition based on said compounds, their use and a method of treating or preventing a condition which development and symptoms are associated with an FAAH enzyme substrate. , , .
EFFECT: new heterocyclic compounds having useful biological properties have been obtained.
10 cl
Title | Year | Author | Number |
---|---|---|---|
UREA COMPOUNDS AND THEIR USE AS ENZYME INHIBITORS | 2013 |
|
RU2685425C2 |
NEW COMPOUNDS - NEUROKININ 1 RECEPTOR ANTAGONIZER | 2013 |
|
RU2631319C2 |
PRIMARY CARBOXAMIDES AS BTK INHIBITORS | 2014 |
|
RU2708395C2 |
PHARMACEUTICAL COMPOUNDS | 2009 |
|
RU2553451C2 |
COMPOUND OF FORMULA (I), PHARMACEUTICAL COMPOSITION, APPLICATION OF COMPOUND OF FORMULA (I) FOR TREATMENT OF HEMATOLOGICAL AND/OR PROLIFERATIVE DISORDERS | 2016 |
|
RU2758259C2 |
THIAZOLPYRIMIDINES | 2012 |
|
RU2610840C2 |
2-(AZAINDOL-2-YL)BENZIMIDAZOLE DERIVATIVES AS PAD4 INHIBITORS | 2012 |
|
RU2611010C2 |
PHARMACEUTICALLY ACTIVE COMPOUNDS AS Axl INHIBITORS | 2011 |
|
RU2573834C2 |
SWEET TASTE AND FLAVOUR MODIFIER | 2013 |
|
RU2666534C2 |
BICYCLIC CONDENSED HETEROARYL OR ARYL COMPOUNDS AS IRAK4 MODULATORS | 2016 |
|
RU2684324C1 |
Authors
Dates
2018-10-31—Published
2014-07-24—Filed